Genus Capital Management Inc. Makes New $14.48 Million Investment in Lam Research Corporation $LRCX

Genus Capital Management Inc. bought a new stake in Lam Research Corporation (NASDAQ:LRCX) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 148,720 shares of the semiconductor company’s stock, valued at approximately $14,476,000. Lam Research makes up approximately 1.8% of Genus Capital Management Inc.’s holdings, making the stock its 12th biggest holding.

A number of other institutional investors have also made changes to their positions in the business. ORBA Wealth Advisors L.L.C. lifted its position in Lam Research by 97.7% during the 2nd quarter. ORBA Wealth Advisors L.L.C. now owns 10,124 shares of the semiconductor company’s stock worth $985,000 after buying an additional 5,004 shares in the last quarter. GPS Wealth Strategies Group LLC raised its stake in shares of Lam Research by 4.5% in the second quarter. GPS Wealth Strategies Group LLC now owns 23,335 shares of the semiconductor company’s stock worth $2,271,000 after acquiring an additional 1,014 shares during the last quarter. Commonwealth Retirement Investments LLC raised its stake in shares of Lam Research by 62.2% in the second quarter. Commonwealth Retirement Investments LLC now owns 36,983 shares of the semiconductor company’s stock worth $3,600,000 after acquiring an additional 14,179 shares during the last quarter. Artemis Wealth Advisors LLC acquired a new position in shares of Lam Research during the second quarter worth approximately $2,920,000. Finally, Homestead Advisers Corp grew its stake in shares of Lam Research by 0.3% during the second quarter. Homestead Advisers Corp now owns 1,135,700 shares of the semiconductor company’s stock valued at $110,549,000 after purchasing an additional 3,900 shares during the last quarter. 84.61% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 62,498 shares of company stock worth $8,875,663. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Down 3.4%

Shares of Lam Research stock opened at $155.78 on Wednesday. The business has a fifty day simple moving average of $131.37 and a 200 day simple moving average of $104.82. The stock has a market cap of $195.66 billion, a PE ratio of 34.31, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $165.22.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company’s revenue was up 27.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, September 24th. This is a boost from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s payout ratio is currently 22.91%.

Analysts Set New Price Targets

Several research firms recently weighed in on LRCX. Stifel Nicolaus set a $160.00 price objective on shares of Lam Research and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Raymond James Financial lifted their target price on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. Needham & Company LLC upped their price target on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b-)” rating on shares of Lam Research in a research report on Wednesday, October 8th. Finally, Hsbc Global Res raised Lam Research to a “hold” rating in a report on Tuesday, September 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and an average price target of $148.54.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.